U.S. FDA authorises 'mix and match' COVID-19 vaccine; backs Moderna, J&J boosters
The HinduU.S. regulators on October 20 signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially. The Food and Drug Administration’s decisions mark a big step toward expanding the U.S. booster campaign, which began with extra doses of the Pfizer vaccine last month. The latest moves would expand by tens of millions the number of Americans eligible for boosters and formally allow “mixing and matching” of shots — making it simpler to get another dose, especially for people who had a side effect from one brand but still want the proven protection of vaccination. For J&J’s single-shot vaccine, the FDA said all U.S. recipients should get a second dose at least two months following their initial vaccination.